stockrow
Saturday 7 November 2026
Export CI’s income statement to Excel — free account
Cigna Group
CI Healthcare Healthcare Plans
Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024.
- Revenue
- +5.64%
- EPS
- −21.6%
- Free cash flow
- −18.1%
- Total debt
- −8.51%
Quarter to September 2026, against a year earlier
293.59
7.89
−2.62%
Follow CI
Alert me
Cigna Group (CI) EBITDA
Cigna Group's EBITDA for fiscal 2025 was $12.0B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $12.7B. Over the past ten years it has ranged from $3.7B (fiscal 2016) to $12.2B (fiscal 2024); the current reading is higher than 91% of that period. Cigna Group ranks 3rd of 12 Healthcare Plans companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $12.0B | (1.78%) |
| FY2024 | $12.2B | 5.37% |
| FY2023 | $11.6B | 1.62% |
| FY2022 | $11.4B | 4.81% |
| FY2021 | $10.9B | (0.83%) |
| FY2020 | $11.0B | (6.59%) |
| FY2019 | $11.7B | 141.57% |
| FY2018 | $4.9B | 7.70% |
| FY2017 | $4.5B | 21.90% |
| FY2016 | $3.7B | (5.47%) |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $3.3B | 10.74% |
| Mar 2026 | $3.0B | (1.92%) |
| Dec 2025 | $3.1B | (6.35%) |
| Sep 2025 | $3.3B | 9.61% |
| 42 more quarters | Free account |
Against its own ten years
Low $3.7B
High $12.2B
Ten-year median
$11.0B
Current reading's percentile
91
EBITDA against peers
| Company | EBITDA |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $28.2B |
| CVS CVS Health Corporation compare | $19.6B |
| CI Cigna Group | $12.7B |
| ELV Elevance Health, Inc. compare | $9.2B |
| HUM Humana Inc. compare | $3.1B |
| CNC Centene Corporation compare | $2.2B |
| OSCR Oscar Health, Inc. compare | $632.0M |
| MOH Molina Healthcare, Inc compare | $333.0M |
| PGNY Progyny, Inc. compare | $117.9M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on CI
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement